Additionally, combined with our clinical BM simples, TNFRSF4 mRNA expression was higher in AML patients than HDs and MDS (EB-1, 2) patients and the expression is positively related with BM blasts percentage. This evidence concerns the gene TNFRSF4 and myelodysplastic syndrome.